Search Results for "repaglinide"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for repaglinide. Results 11 to 13 of 13 total matches.

Noninsulin Drugs for Type 2 Diabetes

   
The Medical Letter on Drugs and Therapeutics • Nov 24, 2025  (Issue 1742)
Meglitinides Nateglinide – generic 60, 120 mg tabs 60-120 mg PO tid28 20.50 Repaglinide – generic 0.5, 1, 2 ...
Diet, exercise, and weight loss can improve glycemic control, but most patients with type 2 diabetes eventually require glucose-lowering pharmacotherapy. An A1C goal of <7% (while minimizing hypoglycemia) is recommended for most patients to prevent or reduce the microvascular complications of diabetes (retinopathy, nephropathy, neuropathy). An A1C target of <8% may be appropriate for patients who are older, have comorbid conditions, or are at risk of serious hypoglycemia-associated adverse events.
Med Lett Drugs Ther. 2025 Nov 24;67(1742):185-92   doi:10.58347/tml.2025.1742a |  Show IntroductionHide Introduction

New Drugs for Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Nov 12, 2012  (Issue 1403)
concentrations of CYP2C8 substrates such as repaglinide (Prandin) and pioglitazone (Actos). It is a weak ...
In recent years, several new drugs have been approved by the FDA for use in multiple sclerosis (MS), and many others are in the pipeline. Most recently, teriflunomide (Aubagio – Genzyme) became the second oral drug to be approved by the FDA for treatment of relapsing forms of MS.
Med Lett Drugs Ther. 2012 Nov 12;54(1403):89-91 |  Show IntroductionHide Introduction

Table: Treatments Considered for COVID-19 (Archived) (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020  (Issue 1595)
: May increase serum concentrations of some drugs such as acetaminophen, penicillins, tazobactam, repaglinide ...
View the Table: Treatments Considered for COVID-19
Med Lett Drugs Ther. 2020 Apr 6;62(1595):e1-289 |  Show IntroductionHide Introduction